|
Symbol Name ID |
Egfl7
EGF-like domain 7 MGI:2449923 |
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| Egfl7Gt(1-13)Stmn/Egfl7Gt(1-13)Stmn involves: 129S1/Sv * 129X1/SvJ |
no abnormal phenotype detected | J:53033 |
| Egfl7Gt(OST80956)Lex/Egfl7Gt(OST80956)Lex involves: 129S5/SvEvBrd * C57BL/6 |
abnormal blood vessel morphology | J:124110 |
| abnormal retina vasculature morphology | J:124110 | |
| abnormal vascular development | J:124110 | |
| absent heartbeat | J:124110 | |
| decreased angiogenesis | J:124110 | |
| edema | J:124110 | |
| hypoxia | J:124110 | |
| lethality throughout fetal growth and development, incomplete penetrance | J:124110 | |
| Egfl7tm1.1Cjku/Egfl7tm1.1Cjku involves: 129/Sv * C57BL/6 |
no abnormal phenotype detected | J:143206 |
| Egfl7tm1Wye/Egfl7tm1Wye B6.129-Egfl7tm1Wye |
abnormal blood vessel morphology | J:124110 |
| abnormal retina vasculature morphology | J:124110 | |
| abnormal vascular development | J:124110 | |
| lethality throughout fetal growth and development, incomplete penetrance | J:124110 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/09/2025 MGI 6.24 |
|
|
|
||